1. Home
  2. CLWT vs NXL Comparison

CLWT vs NXL Comparison

Compare CLWT & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

SELL

Current Price

$1.58

Market Cap

9.5M

ML Signal

SELL

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.39

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLWT
NXL
Founded
1971
2010
Country
Hong Kong
United States
Employees
N/A
8
Industry
Professional and commerical equipment
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
10.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CLWT
NXL
Price
$1.58
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
214.5K
810.7K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.52
Revenue Next Year
N/A
$100.00
P/E Ratio
$17.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.31
52 Week High
$1.63
$2.00

Technical Indicators

Market Signals
Indicator
CLWT
NXL
Relative Strength Index (RSI) 68.15 40.14
Support Level $1.10 $0.35
Resistance Level N/A $0.48
Average True Range (ATR) 0.22 0.06
MACD 0.02 -0.02
Stochastic Oscillator 39.15 6.78

Price Performance

Historical Comparison
CLWT
NXL

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: